Pembrolizumab in Advanced Gastric and Gastroesophageal Junction Cancer

This single cohort study evaluates the safety and efficacy of pembrolizumab in patients with previously treated advanced gastric or gastroesophageal junction cancer.

http://ift.tt/2IsGfwt